86 related articles for article (PubMed ID: 8611133)
1. Gastrin receptor antagonist CI-988 inhibits growth of human colon cancer in vivo and in vitro.
Romani R; Howes LG; Morris DL
Aust N Z J Surg; 1996 Apr; 66(4):235-7. PubMed ID: 8611133
[TBL] [Abstract][Full Text] [Related]
2. Dose dependent in vivo inhibition of human colorectal cancer (LoVo) by the gastrin receptor antagonist, CI-988.
Romani R; Howes LG; Morris DL
Clin Exp Pharmacol Physiol; 1996 May; 23(5):438-40. PubMed ID: 8713686
[TBL] [Abstract][Full Text] [Related]
3. Influence of gastrin on human astrocytic tumor cell proliferation.
Camby I; Salmon I; Danguy A; Pasteels JL; Brotchi J; Martinez J; Kiss R
J Natl Cancer Inst; 1996 May; 88(9):594-600. PubMed ID: 8609660
[TBL] [Abstract][Full Text] [Related]
4. [Gastrin-17 and G17-gly induce proliferation of LoVo cells through the CCK B/gastrin receptor].
Artru P; Attoub S; Levasseur S; Lewin MJ; Bado A
Gastroenterol Clin Biol; 1998; 22(6-7):607-12. PubMed ID: 9762332
[TBL] [Abstract][Full Text] [Related]
5. Divergent proliferative responses to a gastrin receptor ligand in synchronized and unsynchronized rat pancreatic AR42J tumour cells.
Bestervelt L; Barr B; Dethloff L
Cell Signal; 2000 Jan; 12(1):53-61. PubMed ID: 10676848
[TBL] [Abstract][Full Text] [Related]
6. Gastrin sensitivity of primary human colorectal cancer: the effect of gastrin receptor antagonism.
Watson SA; Clifford T; Sykes RE; Robinson E; Steele RJ
Eur J Cancer; 1995 Nov; 31A(12):2086-92. PubMed ID: 8562170
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of gastrin-stimulated cell proliferation by the CCK-B/gastrin receptor ligand CI-988.
Dethloff LA; Barr BM; Bestervelt LL
Food Chem Toxicol; 1999; 37(2-3):105-10. PubMed ID: 10227733
[TBL] [Abstract][Full Text] [Related]
8. Glycine-extended gastrin exerts growth-promoting effects on human colon cancer cells.
Stepan VM; Sawada M; Todisco A; Dickinson CJ
Mol Med; 1999 Mar; 5(3):147-59. PubMed ID: 10404512
[TBL] [Abstract][Full Text] [Related]
9. CI-988 inhibits growth of small cell lung cancer cells.
Moody TW; Jensen RT
J Pharmacol Exp Ther; 2001 Dec; 299(3):1154-60. PubMed ID: 11714907
[TBL] [Abstract][Full Text] [Related]
10. CI-988 Inhibits EGFR Transactivation and Proliferation Caused by Addition of CCK/Gastrin to Lung Cancer Cells.
Moody TW; Nuche-Berenguer B; Moreno P; Jensen RT
J Mol Neurosci; 2015 Jul; 56(3):663-72. PubMed ID: 25761747
[TBL] [Abstract][Full Text] [Related]
11. Gastric effects of the CCK-B/gastrin receptor ligand CI-988 in cynomolgus monkeys.
Dethloff LA; Patmore SJ; Tierney BM; Bestervelt LL; Zandee JC
Food Chem Toxicol; 1998 Jan; 36(1):61-71. PubMed ID: 9487364
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of biologic gastrin activity of compound CI-988 in the isolated, vascularly perfused rat stomach.
Marvik R; Sandvik AK; Waldum HL
Scand J Gastroenterol; 1997 Jun; 32(6):519-22. PubMed ID: 9200280
[TBL] [Abstract][Full Text] [Related]
13. Gastric gland degeneration induced in monkeys by the CCK-B/gastrin receptor antagonist CI-988.
Dethloff LA; Robertson DG; Tierney BM; Breider MA; Bestervelt LL
Toxicol Pathol; 1997; 25(5):441-8. PubMed ID: 9323831
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
Nishida A; Miyata K; Tsutsumi R; Yuki H; Akuzawa S; Kobayashi A; Kamato T; Ito H; Yamano M; Katuyama Y
J Pharmacol Exp Ther; 1994 May; 269(2):725-31. PubMed ID: 7910212
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and receptor binding affinity of cholecystokinin receptor ligands: 2-and 1-indolyl derivatives of PD134308.
Araldi G; Donati D; Oliosi B; Ursini A; van Amsterdam F; Natalini B; Pellicciari R; Tarzia G
Farmaco; 1996 Jul; 51(7):471-6. PubMed ID: 8765669
[TBL] [Abstract][Full Text] [Related]
16. Identification of gastrin as a growth peptide in human pancreatic cancer.
Smith JP; Fantaskey AP; Liu G; Zagon IS
Am J Physiol; 1995 Jan; 268(1 Pt 2):R135-41. PubMed ID: 7840313
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach histidine decarboxylase.
Ding XQ; Chen D; Håkanson R
Gastroenterology; 1995 Oct; 109(4):1181-7. PubMed ID: 7557084
[TBL] [Abstract][Full Text] [Related]
18. Autocrine growth stimulation of human renal Wilms' tumour G401 cells by a gastrin-like peptide.
Blackmore M; Doherty E; Manning JE; Hirst BH
Int J Cancer; 1994 May; 57(3):385-91. PubMed ID: 8169000
[TBL] [Abstract][Full Text] [Related]
19. Distinct receptors for cholecystokinin and gastrin on canine fundic D-cells.
DelValle J; Chiba T; Park J; Yamada T
Am J Physiol; 1993 May; 264(5 Pt 1):G811-5. PubMed ID: 8098910
[TBL] [Abstract][Full Text] [Related]
20. Gastrin stimulates growth of human colon cancer cells via a receptor other than CCK-A or CCK-B.
Bold RJ; Ishizuka J; Townsend CM; Thompson JC
Biochem Biophys Res Commun; 1994 Aug; 202(3):1222-6. PubMed ID: 8060296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
